BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART;VALUE=DATE:20250101
TZNAME:UTC
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:\n\n\n\n\nDate: Tuesday 6th July 2021\nTime: 16:00 - 17:00 BST\
 nOverview\nOur next journal club features two papers on the topic of &ldqu
 o\;The Use of External Controls in Clinical Trials&rdquo\;. The webinar wi
 ll be held on the 6th July 2021 from 4-5pm BST.&nbsp\;\n\nThis event is sp
 onsored by Wiley.\nPlease join us to hear Chris Harbron (Roche) and Margar
 et Gamalo (Pfizer) present their recent work. The webinar will be chaired 
 by Nigel Stallard (Warwick University).\n\nTo view the flyer for this even
 t\, please click here.\n\nRegistration\nREGISTER HERE:&nbsp\;https://zoom.
 us/webinar/register/WN_MLOqHopFSoWYgceT711yTQ\n&nbsp\;\nPresenters \nChris
  Harbron (Roche): The use of external controls: To what extent can it curr
 ently be recommended?\nAuthors: Hans Ulrich Burger\, Christoph Gerlinger\,
  Chris Harbron\, Armin Koch\, Martin Posch\, Justine Rochon and Anja Schie
 l\nPharmaceutical Statistics. 20 21\;1&ndash\; 15\nTo view the slides\, pl
 ease .\nMargaret Gamalo (Pfizer): Propensity score matched augmented contr
 ols in randomized clinical trials: A case study\nAuthors: Junjing Lin\, Ma
 rgaret Gamalo‐Siebers and Ram Tiwari\nPharmaceutical Statistics. 2018\;17:
  629&ndash\;647\nTo view the slides\, please .\nFor each of these publishe
 d papers there will be a 20 minute presentation by the author followed by 
 a 10 minute discussion.\nPapers will be made available to view prior to th
 e meeting and presentation slides will be available a week before the JC. 
 Journal subscribers can access papers at any time.&nbsp\; Audio recordings
  will be available shortly after the JC to download from the PSI website.\
 nThe meetings are open to both PSI and non-PSI members. \n&nbsp\;\n&nbsp\;
DTEND:20210706T160000Z
DTSTAMP:20260721T170136Z
DTSTART:20210706T150000Z
LOCATION:
SEQUENCE:0
SUMMARY:PSI Journal Club: The Use of External Controls in Clinical Trials
UID:RFCALITEM639202500969192553
X-ALT-DESC;FMTTYPE=text/html:<strong><img src="https://www.psiweb.org/image
 s/default-source/default-album/wiley-logo.png?sfvrsn=3f4a7db_0&amp\;sf_sit
 e_temp=true&amp\;sf_site=00000000-0000-0000-0000-000000000000&amp\;MaxWidt
 h=300&amp\;MaxHeight=&amp\;ScaleUp=false&amp\;Quality=High&amp\;Method=Res
 izeFitToAreaArguments&amp\;Signature=720F78E9DA01D841E5ECBADB21CF246D" dat
 a-method="ResizeFitToAreaArguments" data-customsizemethodproperties="{'Max
 Width':'300'\,'MaxHeight':''\,'ScaleUp':false\,'Quality':'High'}" data-dis
 playmode="Custom" alt="Wiley logo" title="Wiley logo" style="float: right\
 ;" /><br />\n<br />\n<br />\n<br />\n<br />\nDate:</strong> Tuesday 6th Ju
 ly 2021<br />\n<strong>Time:</strong> 16:00 - 17:00 BST<br />\n<h4>Overvie
 w</h4>\nOur next journal club features two papers on the topic of &ldquo\;
 The Use of External Controls in Clinical Trials&rdquo\;. The webinar will 
 be held on the 6th July 2021 from 4-5pm BST.&nbsp\;<br />\n<br />\nThis ev
 ent is sponsored by Wiley.<br />\nPlease join us to hear Chris Harbron (Ro
 che) and Margaret Gamalo (Pfizer) present their recent work. The webinar w
 ill be chaired by Nigel Stallard (Warwick University).<br />\n<br />\nTo v
 iew the flyer for this event\, please <strong><a href="https://www.psiweb.
 org/docs/default-source/default-document-library/psi-journal-club-_july-20
 21.pdf?sfvrsn=6cc4a7db_0&sf_site_temp=true&sf_site=00000000-0000-0000-0000
 -000000000000" title="click here">click here</a></strong>.<br />\n<br />\n
 <h4>Registration</h4>\n<p><strong>REGISTER HERE:&nbsp\;<a href="https://zo
 om.us/webinar/register/WN_MLOqHopFSoWYgceT711yTQ" target="_blank">https://
 zoom.us/webinar/register/WN_MLOqHopFSoWYgceT711yTQ</a></strong><br />\n&nb
 sp\;</p>\n<h4>Presenters </h4>\n<p><strong>Chris Harbron (<em>Roche</em>)<
 /strong>: <span style="text-decoration: underline\;"><a href="https://urld
 efense.com/v3/__https:/nam11.safelinks.protection.outlook.com/?url=https*3
 A*2F*2Fonlinelibrary.wiley.com*2Fdoi*2Ffull*2F10.1002*2Fpst.2120&amp\;data
 =04*7C01*7Cpgokani*40amgen.com*7Cdf40a9acbb8043e1bd8608d9115db3ed*7C4b4266
 a6136841afad5a59eb634f7ad8*7C0*7C0*7C637559916441238228*7CUnknown*7CTWFpbG
 Zsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0*3D*7
 C1000&amp\;sdata=22uwsoJpPdPX5*2BFIJ*2BJ6FaGk3zXfYmqcKP*2BMltbVVGE*3D&amp\
 ;reserved=0__\;JSUlJSUlJSUlJSUlJSUlJSUlJSUlJSU!!H9nueQsQ!vRZ2fJfUbTs7trb8C
 9pyHq9iY4SeuHz9HaCxZq8SD6jAeGnrbLR676dCGMMzv7C3T6Qn$">The use of external 
 controls: To what extent can it currently be recommended?</a><br />\n</spa
 n>Authors: Hans Ulrich Burger\, Christoph Gerlinger\, Chris Harbron\, Armi
 n Koch\, Martin Posch\, Justine Rochon and Anja Schiel<br />\nPharmaceutic
 al Statistics. 20 21\;1&ndash\; 15<br />\n<strong>To view the slides\, ple
 ase .</strong></p>\n<p><strong>Margaret Gamalo (<em>Pfizer</em>)</strong>:
  <span style="text-decoration: underline\;"><a href="https://urldefense.co
 m/v3/__https:/nam11.safelinks.protection.outlook.com/?url=https*3A*2F*2Fon
 linelibrary.wiley.com*2Fdoi*2F10.1002*2Fpst.1879&amp\;data=04*7C01*7Cpgoka
 ni*40amgen.com*7Cdf40a9acbb8043e1bd8608d9115db3ed*7C4b4266a6136841afad5a59
 eb634f7ad8*7C0*7C0*7C637559916441238228*7CUnknown*7CTWFpbGZsb3d8eyJWIjoiMC
 4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0*3D*7C1000&amp\;sdata
 =L*2BOxYObrep6MWhnNMrTmUnKJ4FTaJniWSscdmwjtOCQ*3D&amp\;reserved=0__\;JSUlJ
 SUlJSUlJSUlJSUlJSUlJSU!!H9nueQsQ!vRZ2fJfUbTs7trb8C9pyHq9iY4SeuHz9HaCxZq8SD
 6jAeGnrbLR676dCGMMzvzvLzbjf$">Propensity score matched augmented controls 
 in randomized clinical trials: A case study</a><br />\n</span>Authors: Jun
 jing Lin\, Margaret Gamalo‐Siebers and Ram Tiwari<br />\nPharmaceutical St
 atistics. 2018\;17: 629&ndash\;647<br />\n<strong>To view the slides\, ple
 ase .</strong></p>\n<p>For each of these published papers there will be a 
 20 minute presentation by the author followed by a 10 minute discussion.</
 p>\n<p>Papers will be made available to view prior to the meeting and pres
 entation slides will be available a week before the JC. Journal subscriber
 s can access papers at any time.&nbsp\; Audio recordings will be available
  shortly after the JC to download from the PSI website.</p>\n<p>The meetin
 gs are open to both PSI and non-PSI members. </p>\n<p>&nbsp\;</p>\n<p>&nbs
 p\;</p>
END:VEVENT
END:VCALENDAR
